Conversa provides a scalable conversation platform that delivers smart, automated and personalized doctor–patient conversations across health experiences such as chronic condition management, post-discharge and medication adherence. The platform draws from more than 400 biometric devices plus clinical, claims and patient-generated data and can populate actionable data into a patient’s EHR or care management system. Conversa maintains an extensive library of over 50 clinically-intelligent conversation programs covering conditions like asthma, COPD, CHF, diabetes, hypertension and joint replacement. The company reports customer outcomes including a cited 20% reduction in costly post-acute care for joint replacement patients (about $3,400 savings per patient over 90 days) and over 80% of patients reporting higher engagement. Conversa has commercial partnerships and customers including Northwell, Ochsner Health System, Citrus Valley Health Partners and Centura Health’s Penrose St. Francis. The company is expanding product capabilities, its clinical conversation library, customer and distribution operations, and its team to meet growing market demand.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

May 2017